AngioDynamics, Inc. ANGO
Set alert
11.90 USD +0.13 +1.15%
As of Nov 3, 12:20 PM ET
11.62 Day range 12.07
9.39 52-week range 16.29
- YTD
- -7.36%
- 1 year
- +0.55%
- Open
- 11.77
- Prev close
- 11.76
- Mkt cap
- 500.24M
- Vol
- 96.68K
- Avg vol
- 638.21K
- EPS
- -0.78
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 11.62
- High
- 12.07
- Forward P/E
- -36.21
- Beta
- 0.67
- Short ratio
- 2.88
- Inst. own
- 81.31%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 8, 2025
- 50-d avg
- 7.35
- 200-d avg
- 6.77
- 1y target
- 13.00
5Y chart
Events in this range
- Oct 4, 2023Earnings: -0.12; estimate -0.14; surprise 14.29%
- Jan 5, 2024Earnings: -0.05; estimate -0.09; surprise 44.44%
- Apr 4, 2024Earnings: -0.16; estimate -0.14; surprise -14.29%
- Jul 16, 2024Earnings: -0.06; estimate -0.2; surprise 70%
- Jul 17, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jul 17, 2024Rating: Canaccord Genuity · Buy → Buy
- Sep 20, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Oct 3, 2024Earnings: -0.11; estimate -0.15; surprise 26.67%
- Oct 4, 2024Rating: Canaccord Genuity · Buy → Buy
- Oct 4, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 10, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jan 8, 2025Earnings: —; estimate -0.11; surprise —%
Signals (78)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| RSI: Overbought | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| MACD: Sell Signal | Jan 5, 2026 | 10 months ago |
| RSI: Overbought | Dec 1, 2025 | 11 months ago |
| MACD: Buy Signal | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
Newest 20 of 78.
Financial health
Altman Z-Score
2.38 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -12.4×
FY 2017 5y median -12.3× FY 2026
P/S 1.4×
FY 2017 5y median 1.4× FY 2026
P/B 2.7×
FY 2017 5y median 1.8× FY 2026
P/FCF 892×
FY 2017 5y median -28.6× FY 2026
EV/EBITDA 818×
FY 2017 5y median 69.2× FY 2026
EV/Sales 1.2×
FY 2017 5y median 1.2× FY 2026
FCF Yield 0.1%
FY 2017 5y median -1.5% FY 2026
Profitability
Gross Margin 54.6%
FY 2017 5y median 52.4% FY 2026
Operating Margin -12.5%
FY 2017 5y median -13.7% FY 2026
Net Margin -11.5%
FY 2017 5y median -11.6% FY 2026
ROE -21.5%
FY 2017 5y median -18.6% FY 2026
ROIC -20.7%
FY 2017 5y median -19.4% FY 2026
ROA -13.8%
FY 2017 5y median -12.1% FY 2026
Growth (YoY)
Revenue 9.5%
FY 2017 FY 2026
Operating Income 0.1%
FY 2017 FY 2026
EPS (diluted) -6.0%
FY 2017 FY 2026
Free Cash Flow 103.5%
FY 2017 FY 2026
Financial Health
Current Ratio 2.2×
FY 2017 5y median 2.1× FY 2026
Quick Ratio 1.5×
FY 2017 5y median 1.4× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA -110×
FY 2017 5y median 0.4× FY 2026
Interest Coverage -134×
FY 2017 5y median -18.9× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-05-31
